The Aspiration and Biopsy Needles Market is projected to grow at a robust CAGR of 6.8% from 2024 to 2031.
Fine needle aspiration (FNA) is a biopsy technique where a thin needle is inserted into abnormal tissue or body fluid to collect a sample. This procedure helps diagnose or exclude cancer by analyzing the collected sample. FNA is generally safe and is one of the standard needle biopsy methods, alongside core needle biopsy.
Get a Free Sample Research PDF – https://datamintelligence.com/download-sample/aspiration-and-biopsy-needles-market
Market Trends:
The global aspiration and biopsy needles market is expanding due to several key factors. The increasing incidence of various cancers is a major driver of market growth. According to the World Health Organization (WHO), new cancer diagnoses are expected to rise from 12.7 million in 2008 to 21.4 million by 2030. Additionally, cancer was responsible for 9.6 million deaths worldwide in 2018. This surge in cancer cases is prompting governments and health ministries to invest more in medical equipment and initiatives to improve clinical awareness.
Market Segmentation:
By Product Type: Core needle, Fine needle.
By Application: Breast Biopsy, Lung Biopsy, Prostate Biopsy, Bone and Bone Marrow Biopsy.
By Procedure: Image Guided, Non-Image Guided, Others.
By End user: Hospitals, Diagnostic centres, Research Institutes, Clinics.
Get Customization in the report as per your requierments: https://datamintelligence.com/customize/aspiration-and-biopsy-needles-market
Competitive Landscape:
Olympus Corporation
Boston Scientific Corporation
Medtronic plc
Stryker Corporation
Becton
Dickinson and Company
Argon Medical Devices, Inc.
CONMED Corporation
Merit Medical Systems, Inc.
Sterylab s.r.l.
Regional Analysis:
The global Aspiration and Biopsy Needles Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter’s five force analysis. The Aspiration and Biopsy Needles Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.
Key Developments:
On September 2018, Olympus announced that it had received FDA clearance for its new EZ Shot 3 Plus 25 G EUS Needle. This innovation enhances maneuverability and includes a predictability feature that forecasts the trajectory and echogenicity of the needle. The EZ Shot 3 Plus line offers expanded indications for fine needle aspiration (FNA) and fine needle biopsy (FNB).
Related Reports:
Anti Aging Market: https://datamintelligence.com/research-report/anti-aging-market
Glaucoma Therapeutic Market: https://datamintelligence.com/research-report/glaucoma-therapeutic-market
Affiliate Marketing Request here: https://www.datamintelligence.com/affiliate-marketing
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
Write a comment ...